Can a patient registry unlock the secrets of IBD?
NCT ID NCT04243525
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This study is building a registry of medical information from people with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The goal is to use this data to better understand how IBD develops and progresses, which could help improve future treatments and prevention. Adults receiving care at the UPMC IBD clinic may be eligible to participate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This registry could help researchers better understand inflammatory bowel disease, potentially leading to improved therapies and preventive strategies.
- What could go wrong
- As a registry study, it does not test a treatment directly. Its success depends on the quality and completeness of the data collected, and it may not directly result in new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?
- MRI scans may help prevent intestinal damage in Crohn's disease